aTyr Pharma reported $2.86M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Ardelyx USD 128.02M 110.29M Mar/2026
aTyr Pharma USD 2.86M 126.59K Sep/2025
Biogen USD 1.95B 219.1M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Grifols EUR 3.56B 63.19M Dec/2024
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
United Therapeutics USD 178.3M 4.8M Mar/2026